Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2018 Feb 19;11:867–881. doi: 10.2147/OTT.S156891

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© 2018 Chen et al. This work is published and licensed by Dove Medical Press Limited

The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed.

PMC Copyright notice

Effects of recombinant KL, Rap, and 3-MA on kidney function and histopathology in mice with CLP-induced AKI.

Notes: (A) Effects of recombinant KL, Rap, and 3-MA on Scr and BUN levels in mice 24 hours after CLP. *P<0.05 vs CLP+media. (B) Images of H&E staining of kidney tissues 24 hours after CLP showing vacuolar degeneration and loss of brush borders (black arrows) in proximal tubular epithelial cells. Images at 400× magnification were acquired using a biological imaging microscope (BX53; Olympus Corporation, Tokyo, Japan). The mice received recombinant KL (0.01 mg/kg) 1 hour after CLP. Rap (1 mg/kg) or 3-MA (30 mg/kg) was administered by intraperitoneal injection 2 hours before CLP surgery.

Abbreviations: Rap, rapamycin; 3-MA, 3-methyladenine; CLP, cecal ligation and puncture; AKI, acute kidney injury; Scr, serum creatinine; BUN, blood urea nitrogen; CMC, carboxymethyl cellulose.